Diana Shineman, PhD, develops and manages the Foundation's drug discovery portfolio and strategic initiatives. As a measure of success, projects funded by the ADDF have gone on to garner over $2 billion in follow-on funding. Dr. Shineman works with other foundations, government and industry partners to tackle unmet needs in the field. For example, she led an effort to standardize animal model study design to improve research efficiency and translatability.
Dr. Shineman earned her doctorate in cell and molecular biology from the University of Pennsylvania, where she worked in in the Center for Neurodegenerative Disease Research. She also served as an editorial intern for the Journal of Clinical Investigation and was an active member of the Penn Biotechnology Group. Dr. Shineman received a bachelor's degree in biology with a nutrition concentration from Cornell University, where she was named a Howard Hughes Undergraduate Research Scholar. She is a member of several professional societies and has authored numerous articles and peer-reviewed publications.